Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
56%
OVERLAP
BY WEIGHT
39
# OF OVERLAPPING
HOLDINGS
JDOC
70
HOLDINGS
66%
ALSO IN IXJ
IXJ
114
HOLDINGS
35%
ALSO IN JDOC
SECTOR DRIFT (JDOC minus IXJ)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in JDOC |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.4% | 10.3% | 8.4% |
|
ABBVIE INC | 6.6% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 4.9% | 6.2% | 4.9% |
 |
ASTRAZENECA PLC | 4.7% | 3.6% | 3.6% |
|
MERCK & CO. INC. | 4.7% | 3.2% | 3.2% |
JDOC Overweight Relative to IXJ
 |
ROCHE HOLDING AG-BR | 2.3% |
 |
ARGEN-X SE | 2.3% |
|
VEEVA SYSTEMS INC-CLASS A | 2.2% |
|
ABBVIE INC | 1.5% |
|
DANAHER CORP | 1.5% |
|
MERCK & CO. INC. | 1.5% |
|
CVS CAREMARK CORP | 1.5% |
 |
UCB SA | 1.5% |
 |
MEDTRONIC PLC | 1.4% |
|
LONZA GROUP AG-REG | 1.4% |
JDOC Underweight Relative to IXJ
|
ROCHE HOLDING LTD | -3.5% |
|
ABBOTT LABORATORIES | -2.8% |
|
AMGEN INC | -2.3% |
|
NOVARTIS AG | -2.2% |
|
GILEAD SCIENCES INC | -1.9% |
|
PFIZER INC | -1.9% |
|
ELI LILLY & CO | -1.9% |
|
JOHNSON & JOHNSON | -1.4% |
|
GSK PLC | -1.3% |
 |
NOVO NORDISK A/S-B | -1.2% |